Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
Volume: 379, Issue: 22, Pages: 2108 - 2121
Published: Nov 29, 2018
Abstract
Unresectable locally advanced or metastatic triple-negative (hormone-receptor–negative and human epidermal growth factor receptor 2 [HER2]–negative) breast cancer is an aggressive disease with poor outcomes. Nanoparticle albumin-bound (nab)–paclitaxel may enhance the anticancer activity of...
Paper Details
Title
Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
Published Date
Nov 29, 2018
Volume
379
Issue
22
Pages
2108 - 2121
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History